Global Biologics Clinical Manufacturing CDMO Service Supply, Demand and Key Producers, 2023-2029

November 2023 | 143 pages | ID: GEE3D48E0107EN
GlobalInfoResearch

Abstracts

The global Biologics Clinical Manufacturing CDMO Service market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Biologics Clinical Manufacturing CDMO Service demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Biologics Clinical Manufacturing CDMO Service, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biologics Clinical Manufacturing CDMO Service that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Biologics Clinical Manufacturing CDMO Service total market, 2018-2029, (USD Million)

Global Biologics Clinical Manufacturing CDMO Service total market by region & country, CAGR, 2018-2029, (USD Million)

U.S. VS China: Biologics Clinical Manufacturing CDMO Service total market, key domestic companies and share, (USD Million)

Global Biologics Clinical Manufacturing CDMO Service revenue by player and market share 2018-2023, (USD Million)

Global Biologics Clinical Manufacturing CDMO Service total market by Type, CAGR, 2018-2029, (USD Million)

Global Biologics Clinical Manufacturing CDMO Service total market by Application, CAGR, 2018-2029, (USD Million).

This reports profiles major players in the global Biologics Clinical Manufacturing CDMO Service market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Lonza, Intertek, Charles River Laboratories, Bio-Rad, Element, ProPharma, Ascendia and Minaris Regenerative Medicine, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Biologics Clinical Manufacturing CDMO Service market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Biologics Clinical Manufacturing CDMO Service Market, By Region:

• United States
• China
• Europe
• Japan
• South Korea
• ASEAN
• India
• Rest of World

Global Biologics Clinical Manufacturing CDMO Service Market, Segmentation by Type

• Traditional API CDMO
• Highly Potent API CDMO

Global Biologics Clinical Manufacturing CDMO Service Market, Segmentation by Application

• Big Pharmaceutical Companies
• Small and Medium Pharmaceutical Companies

Companies Profiled:

• Thermo Fisher Scientific
• Lonza
• Intertek
• Charles River Laboratories
• Bio-Rad
• Element
• ProPharma
• Ascendia
• Minaris Regenerative Medicine
• TriLink BioTechnologies
• Oakwood Labs
• PiramalPharma Solutions
• Boehringer-Ingelheim
• Wuxi Apptec
• Pharmaron Beijing
• Asymchem Laboratories (Tianjin)
• Porton
• SEQENS

Key Questions Answered

1. How big is the global Biologics Clinical Manufacturing CDMO Service market?

2. What is the demand of the global Biologics Clinical Manufacturing CDMO Service market?

3. What is the year over year growth of the global Biologics Clinical Manufacturing CDMO Service market?

4. What is the total value of the global Biologics Clinical Manufacturing CDMO Service market?

5. Who are the major players in the global Biologics Clinical Manufacturing CDMO Service market?

Contents

1 SUPPLY SUMMARY

1.1 Biologics Clinical Manufacturing CDMO Service Introduction
1.2 World Biologics Clinical Manufacturing CDMO Service Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Biologics Clinical Manufacturing CDMO Service Total Market by Region (by Headquarter Location)
  1.3.1 World Biologics Clinical Manufacturing CDMO Service Market Size by Region (2018-2029), (by Headquarter Location)
  1.3.2 United States Biologics Clinical Manufacturing CDMO Service Market Size (2018-2029)
  1.3.3 China Biologics Clinical Manufacturing CDMO Service Market Size (2018-2029)
  1.3.4 Europe Biologics Clinical Manufacturing CDMO Service Market Size (2018-2029)
  1.3.5 Japan Biologics Clinical Manufacturing CDMO Service Market Size (2018-2029)
  1.3.6 South Korea Biologics Clinical Manufacturing CDMO Service Market Size (2018-2029)
  1.3.7 ASEAN Biologics Clinical Manufacturing CDMO Service Market Size (2018-2029)
  1.3.8 India Biologics Clinical Manufacturing CDMO Service Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Biologics Clinical Manufacturing CDMO Service Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Biologics Clinical Manufacturing CDMO Service Major Market Trends

2 DEMAND SUMMARY

2.1 World Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029)
2.2 World Biologics Clinical Manufacturing CDMO Service Consumption Value by Region
  2.2.1 World Biologics Clinical Manufacturing CDMO Service Consumption Value by Region (2018-2023)
  2.2.2 World Biologics Clinical Manufacturing CDMO Service Consumption Value Forecast by Region (2024-2029)
2.3 United States Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029)
2.4 China Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029)
2.5 Europe Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029)
2.6 Japan Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029)
2.7 South Korea Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029)
2.8 ASEAN Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029)
2.9 India Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029)

3 WORLD BIOLOGICS CLINICAL MANUFACTURING CDMO SERVICE COMPANIES COMPETITIVE ANALYSIS

3.1 World Biologics Clinical Manufacturing CDMO Service Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
  3.2.1 Global Biologics Clinical Manufacturing CDMO Service Industry Rank of Major Players
  3.2.2 Global Concentration Ratios (CR4) for Biologics Clinical Manufacturing CDMO Service in 2022
  3.2.3 Global Concentration Ratios (CR8) for Biologics Clinical Manufacturing CDMO Service in 2022
3.3 Biologics Clinical Manufacturing CDMO Service Company Evaluation Quadrant
3.4 Biologics Clinical Manufacturing CDMO Service Market: Overall Company Footprint Analysis
  3.4.1 Biologics Clinical Manufacturing CDMO Service Market: Region Footprint
  3.4.2 Biologics Clinical Manufacturing CDMO Service Market: Company Product Type Footprint
  3.4.3 Biologics Clinical Manufacturing CDMO Service Market: Company Product Application Footprint
3.5 Competitive Environment
  3.5.1 Historical Structure of the Industry
  3.5.2 Barriers of Market Entry
  3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity

4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)

4.1 United States VS China: Biologics Clinical Manufacturing CDMO Service Revenue Comparison (by Headquarter Location)
  4.1.1 United States VS China: Biologics Clinical Manufacturing CDMO Service Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
  4.1.2 United States VS China: Biologics Clinical Manufacturing CDMO Service Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Biologics Clinical Manufacturing CDMO Service Consumption Value Comparison
  4.2.1 United States VS China: Biologics Clinical Manufacturing CDMO Service Consumption Value Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Biologics Clinical Manufacturing CDMO Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Biologics Clinical Manufacturing CDMO Service Companies and Market Share, 2018-2023
  4.3.1 United States Based Biologics Clinical Manufacturing CDMO Service Companies, Headquarters (States, Country)
  4.3.2 United States Based Companies Biologics Clinical Manufacturing CDMO Service Revenue, (2018-2023)
4.4 China Based Companies Biologics Clinical Manufacturing CDMO Service Revenue and Market Share, 2018-2023
  4.4.1 China Based Biologics Clinical Manufacturing CDMO Service Companies, Company Headquarters (Province, Country)
  4.4.2 China Based Companies Biologics Clinical Manufacturing CDMO Service Revenue, (2018-2023)
4.5 Rest of World Based Biologics Clinical Manufacturing CDMO Service Companies and Market Share, 2018-2023
  4.5.1 Rest of World Based Biologics Clinical Manufacturing CDMO Service Companies, Headquarters (States, Country)
  4.5.2 Rest of World Based Companies Biologics Clinical Manufacturing CDMO Service Revenue, (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Biologics Clinical Manufacturing CDMO Service Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Traditional API CDMO
  5.2.2 Highly Potent API CDMO
5.3 Market Segment by Type
  5.3.1 World Biologics Clinical Manufacturing CDMO Service Market Size by Type (2018-2023)
  5.3.2 World Biologics Clinical Manufacturing CDMO Service Market Size by Type (2024-2029)
  5.3.3 World Biologics Clinical Manufacturing CDMO Service Market Size Market Share by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Biologics Clinical Manufacturing CDMO Service Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Big Pharmaceutical Companies
  6.2.2 Small and Medium Pharmaceutical Companies
6.3 Market Segment by Application
  6.3.1 World Biologics Clinical Manufacturing CDMO Service Market Size by Application (2018-2023)
  6.3.2 World Biologics Clinical Manufacturing CDMO Service Market Size by Application (2024-2029)
  6.3.3 World Biologics Clinical Manufacturing CDMO Service Market Size by Application (2018-2029)

7 COMPANY PROFILES

7.1 Thermo Fisher Scientific
  7.1.1 Thermo Fisher Scientific Details
  7.1.2 Thermo Fisher Scientific Major Business
  7.1.3 Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Product and Services
  7.1.4 Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.1.5 Thermo Fisher Scientific Recent Developments/Updates
  7.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.2 Lonza
  7.2.1 Lonza Details
  7.2.2 Lonza Major Business
  7.2.3 Lonza Biologics Clinical Manufacturing CDMO Service Product and Services
  7.2.4 Lonza Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.2.5 Lonza Recent Developments/Updates
  7.2.6 Lonza Competitive Strengths & Weaknesses
7.3 Intertek
  7.3.1 Intertek Details
  7.3.2 Intertek Major Business
  7.3.3 Intertek Biologics Clinical Manufacturing CDMO Service Product and Services
  7.3.4 Intertek Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.3.5 Intertek Recent Developments/Updates
  7.3.6 Intertek Competitive Strengths & Weaknesses
7.4 Charles River Laboratories
  7.4.1 Charles River Laboratories Details
  7.4.2 Charles River Laboratories Major Business
  7.4.3 Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Product and Services
  7.4.4 Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.4.5 Charles River Laboratories Recent Developments/Updates
  7.4.6 Charles River Laboratories Competitive Strengths & Weaknesses
7.5 Bio-Rad
  7.5.1 Bio-Rad Details
  7.5.2 Bio-Rad Major Business
  7.5.3 Bio-Rad Biologics Clinical Manufacturing CDMO Service Product and Services
  7.5.4 Bio-Rad Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.5.5 Bio-Rad Recent Developments/Updates
  7.5.6 Bio-Rad Competitive Strengths & Weaknesses
7.6 Element
  7.6.1 Element Details
  7.6.2 Element Major Business
  7.6.3 Element Biologics Clinical Manufacturing CDMO Service Product and Services
  7.6.4 Element Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.6.5 Element Recent Developments/Updates
  7.6.6 Element Competitive Strengths & Weaknesses
7.7 ProPharma
  7.7.1 ProPharma Details
  7.7.2 ProPharma Major Business
  7.7.3 ProPharma Biologics Clinical Manufacturing CDMO Service Product and Services
  7.7.4 ProPharma Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.7.5 ProPharma Recent Developments/Updates
  7.7.6 ProPharma Competitive Strengths & Weaknesses
7.8 Ascendia
  7.8.1 Ascendia Details
  7.8.2 Ascendia Major Business
  7.8.3 Ascendia Biologics Clinical Manufacturing CDMO Service Product and Services
  7.8.4 Ascendia Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.8.5 Ascendia Recent Developments/Updates
  7.8.6 Ascendia Competitive Strengths & Weaknesses
7.9 Minaris Regenerative Medicine
  7.9.1 Minaris Regenerative Medicine Details
  7.9.2 Minaris Regenerative Medicine Major Business
  7.9.3 Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Product and Services
  7.9.4 Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.9.5 Minaris Regenerative Medicine Recent Developments/Updates
  7.9.6 Minaris Regenerative Medicine Competitive Strengths & Weaknesses
7.10 TriLink BioTechnologies
  7.10.1 TriLink BioTechnologies Details
  7.10.2 TriLink BioTechnologies Major Business
  7.10.3 TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Product and Services
  7.10.4 TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.10.5 TriLink BioTechnologies Recent Developments/Updates
  7.10.6 TriLink BioTechnologies Competitive Strengths & Weaknesses
7.11 Oakwood Labs
  7.11.1 Oakwood Labs Details
  7.11.2 Oakwood Labs Major Business
  7.11.3 Oakwood Labs Biologics Clinical Manufacturing CDMO Service Product and Services
  7.11.4 Oakwood Labs Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.11.5 Oakwood Labs Recent Developments/Updates
  7.11.6 Oakwood Labs Competitive Strengths & Weaknesses
7.12 PiramalPharma Solutions
  7.12.1 PiramalPharma Solutions Details
  7.12.2 PiramalPharma Solutions Major Business
  7.12.3 PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Product and Services
  7.12.4 PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.12.5 PiramalPharma Solutions Recent Developments/Updates
  7.12.6 PiramalPharma Solutions Competitive Strengths & Weaknesses
7.13 Boehringer-Ingelheim
  7.13.1 Boehringer-Ingelheim Details
  7.13.2 Boehringer-Ingelheim Major Business
  7.13.3 Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Product and Services
  7.13.4 Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.13.5 Boehringer-Ingelheim Recent Developments/Updates
  7.13.6 Boehringer-Ingelheim Competitive Strengths & Weaknesses
7.14 Wuxi Apptec
  7.14.1 Wuxi Apptec Details
  7.14.2 Wuxi Apptec Major Business
  7.14.3 Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Product and Services
  7.14.4 Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.14.5 Wuxi Apptec Recent Developments/Updates
  7.14.6 Wuxi Apptec Competitive Strengths & Weaknesses
7.15 Pharmaron Beijing
  7.15.1 Pharmaron Beijing Details
  7.15.2 Pharmaron Beijing Major Business
  7.15.3 Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Product and Services
  7.15.4 Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.15.5 Pharmaron Beijing Recent Developments/Updates
  7.15.6 Pharmaron Beijing Competitive Strengths & Weaknesses
7.16 Asymchem Laboratories (Tianjin)
  7.16.1 Asymchem Laboratories (Tianjin) Details
  7.16.2 Asymchem Laboratories (Tianjin) Major Business
  7.16.3 Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Product and Services
  7.16.4 Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.16.5 Asymchem Laboratories (Tianjin) Recent Developments/Updates
  7.16.6 Asymchem Laboratories (Tianjin) Competitive Strengths & Weaknesses
7.17 Porton
  7.17.1 Porton Details
  7.17.2 Porton Major Business
  7.17.3 Porton Biologics Clinical Manufacturing CDMO Service Product and Services
  7.17.4 Porton Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.17.5 Porton Recent Developments/Updates
  7.17.6 Porton Competitive Strengths & Weaknesses
7.18 SEQENS
  7.18.1 SEQENS Details
  7.18.2 SEQENS Major Business
  7.18.3 SEQENS Biologics Clinical Manufacturing CDMO Service Product and Services
  7.18.4 SEQENS Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023)
  7.18.5 SEQENS Recent Developments/Updates
  7.18.6 SEQENS Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Biologics Clinical Manufacturing CDMO Service Industry Chain
8.2 Biologics Clinical Manufacturing CDMO Service Upstream Analysis
8.3 Biologics Clinical Manufacturing CDMO Service Midstream Analysis
8.4 Biologics Clinical Manufacturing CDMO Service Downstream Analysis

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. World Biologics Clinical Manufacturing CDMO Service Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Biologics Clinical Manufacturing CDMO Service Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Biologics Clinical Manufacturing CDMO Service Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Biologics Clinical Manufacturing CDMO Service Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Biologics Clinical Manufacturing CDMO Service Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biologics Clinical Manufacturing CDMO Service Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Biologics Clinical Manufacturing CDMO Service Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Biologics Clinical Manufacturing CDMO Service Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Biologics Clinical Manufacturing CDMO Service Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Biologics Clinical Manufacturing CDMO Service Players in 2022
Table 12. World Biologics Clinical Manufacturing CDMO Service Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Biologics Clinical Manufacturing CDMO Service Company Evaluation Quadrant
Table 14. Head Office of Key Biologics Clinical Manufacturing CDMO Service Player
Table 15. Biologics Clinical Manufacturing CDMO Service Market: Company Product Type Footprint
Table 16. Biologics Clinical Manufacturing CDMO Service Market: Company Product Application Footprint
Table 17. Biologics Clinical Manufacturing CDMO Service Mergers & Acquisitions Activity
Table 18. United States VS China Biologics Clinical Manufacturing CDMO Service Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Biologics Clinical Manufacturing CDMO Service Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Biologics Clinical Manufacturing CDMO Service Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biologics Clinical Manufacturing CDMO Service Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Biologics Clinical Manufacturing CDMO Service Revenue Market Share (2018-2023)
Table 23. China Based Biologics Clinical Manufacturing CDMO Service Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biologics Clinical Manufacturing CDMO Service Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Biologics Clinical Manufacturing CDMO Service Revenue Market Share (2018-2023)
Table 26. Rest of World Based Biologics Clinical Manufacturing CDMO Service Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Biologics Clinical Manufacturing CDMO Service Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Biologics Clinical Manufacturing CDMO Service Revenue Market Share (2018-2023)
Table 29. World Biologics Clinical Manufacturing CDMO Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Biologics Clinical Manufacturing CDMO Service Market Size by Type (2018-2023) & (USD Million)
Table 31. World Biologics Clinical Manufacturing CDMO Service Market Size by Type (2024-2029) & (USD Million)
Table 32. World Biologics Clinical Manufacturing CDMO Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Biologics Clinical Manufacturing CDMO Service Market Size by Application (2018-2023) & (USD Million)
Table 34. World Biologics Clinical Manufacturing CDMO Service Market Size by Application (2024-2029) & (USD Million)
Table 35. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Product and Services
Table 38. Thermo Fisher Scientific Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. Thermo Fisher Scientific Recent Developments/Updates
Table 40. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 41. Lonza Basic Information, Area Served and Competitors
Table 42. Lonza Major Business
Table 43. Lonza Biologics Clinical Manufacturing CDMO Service Product and Services
Table 44. Lonza Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Lonza Recent Developments/Updates
Table 46. Lonza Competitive Strengths & Weaknesses
Table 47. Intertek Basic Information, Area Served and Competitors
Table 48. Intertek Major Business
Table 49. Intertek Biologics Clinical Manufacturing CDMO Service Product and Services
Table 50. Intertek Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Intertek Recent Developments/Updates
Table 52. Intertek Competitive Strengths & Weaknesses
Table 53. Charles River Laboratories Basic Information, Area Served and Competitors
Table 54. Charles River Laboratories Major Business
Table 55. Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Product and Services
Table 56. Charles River Laboratories Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Charles River Laboratories Recent Developments/Updates
Table 58. Charles River Laboratories Competitive Strengths & Weaknesses
Table 59. Bio-Rad Basic Information, Area Served and Competitors
Table 60. Bio-Rad Major Business
Table 61. Bio-Rad Biologics Clinical Manufacturing CDMO Service Product and Services
Table 62. Bio-Rad Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. Bio-Rad Recent Developments/Updates
Table 64. Bio-Rad Competitive Strengths & Weaknesses
Table 65. Element Basic Information, Area Served and Competitors
Table 66. Element Major Business
Table 67. Element Biologics Clinical Manufacturing CDMO Service Product and Services
Table 68. Element Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Element Recent Developments/Updates
Table 70. Element Competitive Strengths & Weaknesses
Table 71. ProPharma Basic Information, Area Served and Competitors
Table 72. ProPharma Major Business
Table 73. ProPharma Biologics Clinical Manufacturing CDMO Service Product and Services
Table 74. ProPharma Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. ProPharma Recent Developments/Updates
Table 76. ProPharma Competitive Strengths & Weaknesses
Table 77. Ascendia Basic Information, Area Served and Competitors
Table 78. Ascendia Major Business
Table 79. Ascendia Biologics Clinical Manufacturing CDMO Service Product and Services
Table 80. Ascendia Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Ascendia Recent Developments/Updates
Table 82. Ascendia Competitive Strengths & Weaknesses
Table 83. Minaris Regenerative Medicine Basic Information, Area Served and Competitors
Table 84. Minaris Regenerative Medicine Major Business
Table 85. Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Product and Services
Table 86. Minaris Regenerative Medicine Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Minaris Regenerative Medicine Recent Developments/Updates
Table 88. Minaris Regenerative Medicine Competitive Strengths & Weaknesses
Table 89. TriLink BioTechnologies Basic Information, Area Served and Competitors
Table 90. TriLink BioTechnologies Major Business
Table 91. TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Product and Services
Table 92. TriLink BioTechnologies Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. TriLink BioTechnologies Recent Developments/Updates
Table 94. TriLink BioTechnologies Competitive Strengths & Weaknesses
Table 95. Oakwood Labs Basic Information, Area Served and Competitors
Table 96. Oakwood Labs Major Business
Table 97. Oakwood Labs Biologics Clinical Manufacturing CDMO Service Product and Services
Table 98. Oakwood Labs Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 99. Oakwood Labs Recent Developments/Updates
Table 100. Oakwood Labs Competitive Strengths & Weaknesses
Table 101. PiramalPharma Solutions Basic Information, Area Served and Competitors
Table 102. PiramalPharma Solutions Major Business
Table 103. PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Product and Services
Table 104. PiramalPharma Solutions Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 105. PiramalPharma Solutions Recent Developments/Updates
Table 106. PiramalPharma Solutions Competitive Strengths & Weaknesses
Table 107. Boehringer-Ingelheim Basic Information, Area Served and Competitors
Table 108. Boehringer-Ingelheim Major Business
Table 109. Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Product and Services
Table 110. Boehringer-Ingelheim Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 111. Boehringer-Ingelheim Recent Developments/Updates
Table 112. Boehringer-Ingelheim Competitive Strengths & Weaknesses
Table 113. Wuxi Apptec Basic Information, Area Served and Competitors
Table 114. Wuxi Apptec Major Business
Table 115. Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Product and Services
Table 116. Wuxi Apptec Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 117. Wuxi Apptec Recent Developments/Updates
Table 118. Wuxi Apptec Competitive Strengths & Weaknesses
Table 119. Pharmaron Beijing Basic Information, Area Served and Competitors
Table 120. Pharmaron Beijing Major Business
Table 121. Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Product and Services
Table 122. Pharmaron Beijing Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 123. Pharmaron Beijing Recent Developments/Updates
Table 124. Pharmaron Beijing Competitive Strengths & Weaknesses
Table 125. Asymchem Laboratories (Tianjin) Basic Information, Area Served and Competitors
Table 126. Asymchem Laboratories (Tianjin) Major Business
Table 127. Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Product and Services
Table 128. Asymchem Laboratories (Tianjin) Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 129. Asymchem Laboratories (Tianjin) Recent Developments/Updates
Table 130. Asymchem Laboratories (Tianjin) Competitive Strengths & Weaknesses
Table 131. Porton Basic Information, Area Served and Competitors
Table 132. Porton Major Business
Table 133. Porton Biologics Clinical Manufacturing CDMO Service Product and Services
Table 134. Porton Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 135. Porton Recent Developments/Updates
Table 136. SEQENS Basic Information, Area Served and Competitors
Table 137. SEQENS Major Business
Table 138. SEQENS Biologics Clinical Manufacturing CDMO Service Product and Services
Table 139. SEQENS Biologics Clinical Manufacturing CDMO Service Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 140. Global Key Players of Biologics Clinical Manufacturing CDMO Service Upstream (Raw Materials)
Table 141. Biologics Clinical Manufacturing CDMO Service Typical Customers

LIST OF FIGURE

Figure 1. Biologics Clinical Manufacturing CDMO Service Picture
Figure 2. World Biologics Clinical Manufacturing CDMO Service Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Biologics Clinical Manufacturing CDMO Service Total Market Size (2018-2029) & (USD Million)
Figure 4. World Biologics Clinical Manufacturing CDMO Service Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Biologics Clinical Manufacturing CDMO Service Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Biologics Clinical Manufacturing CDMO Service Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Biologics Clinical Manufacturing CDMO Service Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Biologics Clinical Manufacturing CDMO Service Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Biologics Clinical Manufacturing CDMO Service Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Biologics Clinical Manufacturing CDMO Service Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Biologics Clinical Manufacturing CDMO Service Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Biologics Clinical Manufacturing CDMO Service Revenue (2018-2029) & (USD Million)
Figure 13. Biologics Clinical Manufacturing CDMO Service Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 16. World Biologics Clinical Manufacturing CDMO Service Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 18. China Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 23. India Biologics Clinical Manufacturing CDMO Service Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Biologics Clinical Manufacturing CDMO Service by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biologics Clinical Manufacturing CDMO Service Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biologics Clinical Manufacturing CDMO Service Markets in 2022
Figure 27. United States VS China: Biologics Clinical Manufacturing CDMO Service Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Biologics Clinical Manufacturing CDMO Service Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Biologics Clinical Manufacturing CDMO Service Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Biologics Clinical Manufacturing CDMO Service Market Size Market Share by Type in 2022
Figure 31. Traditional API CDMO
Figure 32. Highly Potent API CDMO
Figure 33. World Biologics Clinical Manufacturing CDMO Service Market Size Market Share by Type (2018-2029)
Figure 34. World Biologics Clinical Manufacturing CDMO Service Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 35. World Biologics Clinical Manufacturing CDMO Service Market Size Market Share by Application in 2022
Figure 36. Big Pharmaceutical Companies
Figure 37. Small and Medium Pharmaceutical Companies
Figure 38. Biologics Clinical Manufacturing CDMO Service Industrial Chain
Figure 39. Methodology
Figure 40. Research Process and Data Source